John Wallace
Chairman at Antibe Holdings, Inc.
Net worth: 279 012 $ as of 2024-04-29
John Wallace active positions
| Companies | Position | Start | End |
|---|---|---|---|
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Chairman | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| McMaster University | Corporate Officer/Principal | - | - |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Director/Board Member | - | - |
| Cumming School of Medicine | Corporate Officer/Principal | - | - |
Career history of John Wallace
Former positions of John Wallace
| Companies | Position | Start | End |
|---|---|---|---|
| Farncombe Family Digestive Health Research Institute | Director/Board Member | 2008-12-31 | 2011-12-31 |
| NICOX SA | Founder | - | - |
Canadian Association of Gastroenterology
 Canadian Association of Gastroenterology Miscellaneous Commercial ServicesCommercial Services Canadian Association of Gastroenterology promotes the study of the digestive tract in health and disease. It supports the development and maintenance of formal educational research component within Gastroenterology in Canada. The company was founded in 1962 and is headquartered in Oakville, Canada. | President | - | - |
| ANTIBE THERAPEUTICS INC. | Director/Board Member | 2009-05-04 | - |
| Chairman | 2009-05-04 | 2013-08-29 | |
| Chief Tech/Sci/R&D Officer | 2009-05-04 | - | |
| Founder | 2009-05-04 | - |
Training of John Wallace
| Queen's University | Graduate Degree |
| University of Toronto | Doctorate Degree |
| University of Birmingham | Masters Business Admin |
Statistics
International
| Canada | 10 |
| France | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 3 |
| Chairman | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| NICOX SA | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
Canadian Association of Gastroenterology
Canadian Association of Gastroenterology Miscellaneous Commercial ServicesCommercial Services Canadian Association of Gastroenterology promotes the study of the digestive tract in health and disease. It supports the development and maintenance of formal educational research component within Gastroenterology in Canada. The company was founded in 1962 and is headquartered in Oakville, Canada. | Commercial Services |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Finance |
| Farncombe Family Digestive Health Research Institute |
- Stock Market
- Insiders
- John Wallace
- Experience
